Cancer Drugs

Feb 11, 2016 at 09:04 | Source: PTI
As per the government order last week, the Central Board of Excise and Customs has withdrawn exemption on as many as 74 drugs, including life savings drugs for treating cancer and HIV, from levy of customs duty.
Feb 10, 2016 at 16:18 | Source: PTI
Defending the move to end thecustoms duty exemption for import of 76 life saving drugsincluding those for treating cancer, AIDS and haemophilia,Government has said Indian manufacturers are already sellingmost of these drugs at cheaper prices.
Feb 08, 2016 at 08:53 | Source: PTI
The Mumbai-based company has included its two drugs -- Abirapro prescribed for prostate cancer and Evermil, indicated for different cancers, such as breast and renal cell carcinoma -- under the scheme. Currently, Abirapro 250 mg in 120 pack size is priced at Rs 39,990.
Feb 02, 2016 at 09:57 | Source: Moneycontrol.com
The company's subsidiary has received final approval for Imatinib Mesylate from Food and Drug Administration (FDA) in December 2015.
Jan 22, 2016 at 18:45 | Source: Reuters
India's federal drugs controller issued an alert on Thursday, asking states to ensure Swiss drugmaker Roche's cancer treatment Avastin was not administered to treat eyes, after its usage hampered vision in 15 patients.
Jan 22, 2016 at 08:19 | Source: Reuters
Despite being a cancer drug, Avastin is often used by doctors globally for eye ailments even though it does not have US Food and Drug Administration approval for that purpose.
Jan 20, 2016 at 10:25 | Source: Reuters
Avastin is a cancer drug but is often used by doctors to treat vision loss even though it has not been approved by the US Food and Drug Administration for that purpose. Studies have shown that eye injections of Avastin curb vision loss.
Jan 12, 2016 at 19:44 | Source: PTI
As part of its strategic priorities for the next decade, the Mumbai-based firm also wants to build leadership position in various therapeutic segments, including dermatology and cancer treatment drugs.
Jan 08, 2016 at 13:15 | Source: PTI
The novel clinical development candidate, GBR1342 is an antibody based on the company's proprietary BEAT platform, Glenmark Pharmaceuticals said in a regulatory filing. BEAT is Glenmark's technology for production of bi-specific antibodies.
Jan 05, 2016 at 11:18 | Source: Moneycontrol.com
"Glenmark reached an agreement with Roche/OSI regarding ongoing patent disputes relating to the anti-cancer medicine - Erlotinib Hydrochloride," says the Mumbai-based pharma company in its filing.
Messages on Cancer Drugs »

sanecounsel

Platinum Member

134 Followers

Biocon  

the outcome of the Delhi High Court case brought by Roche against Biocon and Mylan in February gains significance. Roche has alleged that Biocon/Mylan has misrepresented its drugs as a biosimilar of its bestselling breast cancer drug, Trastuzumab (Herceptin), without having undergone the required

10.04 AM Jul 8th 2014

Sun Pharma  

Sun Pharma recalls 200 vials of cancer drug from US market. After seeing this I am sure Marketman will make his appearance on this forum/

7.17 PM Jul 3rd 2014

sahil456

New Member

4 Followers

Just Posted  

Sun Pharma recalls 200 vials of cancer drug - FDA

1.28 PM Jul 3rd 2014

jackson 333

New Member

8 Followers

Aanjaneya Life  

Do not know but its a strong possibility. As per Annual Report posted on this site,Unit 3 is to be an state of the art ultramodern facility for anti-cancer drugs likely to be ready for production by Oct 14. Please verify the news and keep updating.

1.30 PM Jul 1st 2014

marketman

Platinum Member

25381 Followers

Natco Pharma  

.... After that it has been rising with the improved business.... Company is specialised in manufacturing low priced cancer drugs.... Its promoter CEO looks very tall about 6`3".... Yet to give bonus or stock split.....

10.18 AM Jun 30th 2014

Sunn1

New Member

0 Follower

Pfizer  

french biotech cellectis surges as pfizer signs cancer drug deal... source: reuters

1.21 PM Jun 19th 2014

shivangee

Silver Member

10 Followers

Pfizer  

Promising cancer drug data helps AstraZeneca in Pfizer fight

2.01 PM May 16th 2014

shivangee

Silver Member

10 Followers

Just Posted  

Promising cancer drug data helps AstraZeneca in Pfizer fight

1.20 PM May 16th 2014

cjvora

Gold Member

76 Followers

Sun Pharma  

SETTLEMENT WITH NOVARTIS AND LAUNCH CANCER DRUG IN 2016 MAKE THIS STOCK ALL TIME HIGH AT CURRENT TIME.......700 plus in coming days! just hold this gem stock in ur hand......good luck.

12.45 PM May 15th 2014

balvirsingh
123

Gold Member

32 Followers

Aanjaneya Life  

also you will know the position of Mire BV in cancer drug industry in that article.

2.04 PM May 13th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.